Growth hormone did not enhance mucosal hyperplasia after small-bowel resection

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 4, 1996, Pages 349-354

  Park, J H Y ^a   Vanderhoof, J A ^b  

^a Hallym University   (South Korea)

^b NONE

Author keywords

Insulin like growth factor binding proteins; Insulin like growth factor I

Indexed keywords

ALPHA GLUCOSIDASE; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; HYPERPLASIA; MALE; MALNUTRITION; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE MUCOSA; SMALL INTESTINE RESECTION; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

EID: 0029871001     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609006409     Document Type: Article

References (46)

1. Kopple JD. The rationale for the use of growth hormone or insulin-like growth factor I in adult patients with renal failure. Miner Electrolyte Metab 1992;18:269-75.
2. Daughaday WH, Rotwein P. Insulin-like growth factor I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentration. Endocr Rev 1989;10:68-91.
3. Park JHY, McCusker RH, Vanderhoof JA, Mohammadpour H, Harty RF, MacDonald RG. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Endocrinology 1992;131:1359-68.
4. Lemmey AB, Martin AA, Read LC, Tomas FM, Owens PC, Ballard FJ. IGF-I and the truncated analogues des-(1-3)-IGF-I enhance growth in rats after gut resection. Am J Physiol 1991;260(Endocrinol Metab 23):E213-9.
5. Vanderhoof JA, McCusker RH, Clark R, Mohammadpour H, Blackwood DJ, Harty RF, et al. Truncated and native insulin-like growth factor I enhance mucosal adaptation after jejunoileal resection. Gastroenterology 1992;102:1949-56.
6. Rechler MM, Brown AL. Insulin-like growth factor binding proteins: gene structure and expression. Growth Reg 1992;2: 55-68.
7. Clemmons DR. IGF binding proteins: regulation of cellular actions. Growth Reg 1992;2:80-7.
8. Johnson LR. Regulation of gastrointestinal growth. In: Johnson L, editor. Physiology of the gastrointestinal tract. New York: Raven Press, 1987:169-96.
9. Baxter RC. The somatomedins: insulin-like growth factors. Adv Clin Chem 1986;25:49-112.
10. Burgess EJ. Insulin-like growth factor 1: a valid nutritional indicator during parenteral feeding of patients suffering an acute phase response. Ann Clin Biochem 1992;29:37-144.
11. Hill KK, Hill DB, McClain MP, Humphries LL, McClain CJ. Serum insulin-like growth factor-I concentrations in the recovery of patients with anorexia nervosa. J Am Coll Nutr 1993;12:475-8.
12. Clemmons DR, Underwood LE, Dickerson N, Brown RO, Hak LJ, MacPhee RD, et al. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985;41:191-8.
13. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983;71:175-82.
14. Scott CD, Baxter RC. Production of insulin-like growth factor-I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology 1986;119: 2346-52.
15. Underwood LE, Clemmons DR, Maes M, D'Ercole AJ, Ketelslegers JM. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Horm Res 1986;24:166-76.
16. Grant DB, Hambley J, Becker D, Pimstone BE. Reduced sulfation factor in undernourished children. Arch Dis Child 1973;48:596-600.
17. Maes M, Underwood LE, Ketelslegers JM. Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites. J Endocrinol 1983;97:243-51.
18. Maes M, Underwood LE, Ketelslegers JM. Low serum somatomedin-C in protein deficiency: relationship with changes in liver somatogenic and lactogenic binding sites. Mol Cell Endocrinol 1984;37:301-9.
19. Hintz RR, Suskind R, Amatayakul K, Thanangkul O, Olson R. Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition. J Pediatr 1978;92:153-6.
20. Marks V, Howorth N, Greenwood FC. Plasma growth-hormone levels in chronic starvation in man. Nature 1965;208:686-7.
21. Pimstone BE, Wittmann W, Hansen JDL, Murray P. Growth hormone and kwashiorkor. Lancet 1966;2:779-80.
22. Munro HN, Fleck A. Recent developments in the measurement of nucleic acids in biological materials. Analyst 1966;91:78-87.
23. Giles KW, Myers A. Improved diphenylamine method for estimation of DNA. Nature 1965;206:93-4.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
25. Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem 1964;7:18-25.
26. Rivero FL, Goya L, Pascual-Leone AM. Comparison of extraction methods for insulin-like growth factor-binding proteins prior to measurement of insulin-like growth factor-I in undernourished neonatal and adult rat serum. J Endocrinol 1994;140:257-63.
27. McCusker RH, Cumacho-Hubner C, Clemmons DR. Identification of the types of insulin-like growth factor binding proteins that are secreted by muscle cells in vitro. J Biol Chem 1989; 264:7775-80.
28. Steel RGD, Torrie JH. Principles and procedures of statistics. 2nd ed. New York: McGraw-Hill, 1980.
29. Park JHY, McCusker RH, Mohammadpour H, Blackwood DJ, Hrbek M, Vanderhoof JA. Dexamethasone inhibits mucosal adaptation after small bowel resection. Am J Physiol 1994;266 (Gastrointest Liver Physiol 29):497-503.
30. Rechler MM, Nissley SP. Insulin-like growth factors. In: Sporn MB, Robert AB, editors. Peptide growth factors and their receptors I. Berlin: Springer-Verlag, 1990:263-80.
31. Szabo L, Mottershead DG, Ballard FJ, Wallace JC. The bovine insulin-like growth factor (IGF) binding purified from conditioned medium requires the N-terminal tripeptide in IGF-I for binding. Biochem Biophys Res Commun 1988;151:207-14.
32. Shulman DI, Hu CS, Duckett G, Lavallee-Grey M. Effects of short-term hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol N992;14:3-11.
33. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutin RR. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990;12: 424-31.
34. Domene H, Krishnamurthi K, Eshet R, Gilad I, Laron Z, Koch I, et al. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of Juvenile rats. Endocrinology 1983;133:675-82.
35. Leblond CP, Carriere RM. The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa of the rats. Endocrinology 1955;56:261-6.
36. Albiston AL, Taylot RG, Herington AC, Beveridge DJ, Fuller PJ. Divergent ileal IGF-I and IGFBP-3 gene expression after small bowel resection: a novel mechanism to amplify IGF action? Mol Cell Endocrinol 1992;83:R17-R20.
37. Peter MA, Winterhalter KH, Boni-Schnetzler M, Froesch ER, Zapf J. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat adipose tissue. Endocrinology 1993;133:2624-31.
38. Luo J, Murphy LJ. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rats. Endocrinology 1989;125:165-71.
39. Glasscock GF, Hein AN, Miller JA, Hintz RL, Rosenfeld RG. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine of growth hormone, on the neonatal hypophysectomized rats. Endocrinology 1992; 130:203-10.
40. Philips LS, Young HS. Nutrition and somatomedin. I. Effect of fasting and refeeding on serum somatomedin activity and cartilage growth activity in rats. Endocrinology 1976;99: 304-14.
41. Takano K, Hizuka N, Kawai K, Shizume K. Effect of growth hormone and nutrition on the level of somatomedin A in the rat. Acta Endocrinol (Copenh) 1978;87:485-94.
42. Shapiro B, Pimstone BL. Sulphation factor (somatomedin activity) in experimental protein malnutrition in the rat. J Endocrinol 1978;77:233-40.
43. Mares M, Amand Y, Underwood LE, Maiter D, Ketelslegers JM. Decreased serum insulin-like growth factor-I response to growth hormone in hypophysectomized rats fed a low protein diet: evidence for a postreceptor defect. Acta Endocrinol (Copenh) 1988;117:320-7.
44. Wood WI, Cachianes G, Henzel WJ, Winslow CA, Spencer SA, Hellmiss R, et al. Cloning and expression of the GH dependent insulin like growth factor binding protein. Mol Endocrinol 1988;2:1176-85.
45. Shimasaki S, Uchiyama F, Shimonaka M, Ling N. Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol Endocrinol 1990;4:1451-58.
46. 2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors. Biochem Biophys Res Commun 1988;156:1187-94.